The FDA rejected MDMA therapy as a treatment for PTSD, with the advisory committee saying there is not enough evidence it was safe or effective. A setback to the use of psychedelics for the treatment ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Advocates are pushing for approval of psychedelic-assisted therapy from the FDA, seeking a means of therapy without fear of ...

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

Delve into the psychedelic-assisted therapy market and investors' sentiment after the FDA's decision about Lykos' MDMA ...

A Boulder-based therapist said he's baffled and disappointed by federal regulators’ decision last month not to approve a ...